Exploring the 2022 Updated HIV Treatment and Prevention Guidelines
Although human immunodeficiency virus (HIV) is a global health problem, pharmacists may be unfamiliar with principles of antiretroviral therapy due to its complexity and relatively infrequent use when compared to other common disease treatments. With transformative new developments in clinical practice, pharmacists must understand how to implement these recommendations that have been shown to reduce morbidity, mortality, and disease transmission. This presentation will provide an overview of pharmacotherapy for the prevention of HIV, and present important considerations for selecting an initial regimen for newly diagnosed patients.
Learning Objectives
At the completion of this activity, the participant should be able to:
- Describe the history of HIV treatment and recent significant advances in pharmacotherapy for HIV.
- Recognize workplace-specific clinical practices, protocols, and resources for the prevention, diagnosis, and treatment initiation of HIV
- Recall important clinical pearls for preventing, selecting, and initiating treatment regimens for HIV.
Presenter
Erin Persico, PharmD, is a PGY1 Pharmacy Resident at Baystate Medical Center. She graduated from the University of Rhode Island College of Pharmacy with her PharmD in 2022. Her clinical interests include internal medicine, emergency medicine, and oncology.
Course Fee: Free for MCPHS alumni, full-time staff, and for all other professionals.
Release Date: June 6, 2023
Expiration Date: June 6, 2024
ACPE UAN: 0026-0000-23-010-H02-P | Knowledge
ACPE Topic Designator: HIV/AIDS Therapy
Contact Hours: 1.0 (0.1 CEU)
After registering or logging into mcphsce.org, you can view CE modules in our library.
Massachusetts College of Pharmacy and Health Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. MCPHS designates this educational activity for a total of 1.0 contact hours (0.1 CEUs).
To receive credit, participants must complete pre and post-assessments, view the entire presentation, and evaluate the session. Participant credit will be reported to the CPE Monitor upon conclusion. Transcripts may be printed from the CPE Monitor.
The policy of Massachusetts College of Pharmacy and Health Sciences is ensuring balance, independence, objectivity, and scientific rigor in all of its educational activities. Any individuals involved in planning or content creation for a continuing education activity are required to disclose financial relationships with ineligible companies that have occurred within the last 24 months. The intent of the policy is to identify and mitigate potential conflicts of interest that may affect the activity. All clinical medicine recommendations must be based on evidence accepted within the medical profession.
Erin Persico, PharmD, has no relevant financial relationships with ineligible companies to disclose.
Content reviewer Michael Lorenzo, PharmD, has no relevant financial relationships with ineligible companies.
Massachusetts College of Pharmacy and Health Sciences Continuing Education staff members hold no financial relationships with ineligible companies related to the content of this presentation.
Massachusetts College of Pharmacy and Health Sciences will identify, review, and mitigate all conflicts of interest disclosed prior to delivery of an educational activity to learners. Disclosure of a relationship is not intended to suggest or condone bias in any presentation, but provides participants with information that may be of potential importance when they are evaluating content.